By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

GLP-1 weight loss drugs have quickly moved from medical journals to household conversations, reshaping how Americans think ...

Soaring in popularity, GLP-1 medications—from weekly injections to newly available pills—are rapidly reshaping how Americans ...

This review examines how GLP-1 receptor agonists may influence neurodegenerative disease biology through metabolic, ...

Wegovy is now available in pill form. Are patches next?

There has been increased interest in over-the-counter GLP-1 patches. If you’re thinking about using, here’s what you should know.

The first GLP-1 (Glucagon-Like Peptide-1) medication was approved for weight loss use more than a decade ago with new more effective versions being approved by the FDA over the past few years. As the ...

LifeVantage announces improved results from its MindBody GLP-1 System clinical trials, showing over 200% average increase in GLP-1. LifeVantage Corporation has revealed promising new results from its ...

WHO guidelines conditionally endorse long-term GLP-1 therapy for obesity, emphasizing lifestyle modifications and addressing affordability and access challenges. GLP-1 therapies are included in the ...

PHILADELPHIA -- At Roxborough Memorial Hospital in Philadelphia, surgeon Piotr Krecioch has his hands full launching a program offering surgical interventions to treat obesity. One in three ...

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

Experts at ISC 2026 highlighted growing evidence that GLP-1 receptor agonists may reduce stroke risk and support brain health through anti-inflammatory, vascular, and neuroprotective mechanisms.